173 related articles for article (PubMed ID: 38108602)
1. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.
Hellings PW; Alobid I; Anselmo-Lima WT; Bernal-Sprekelsen M; Bjermer L; Caulley L; Chaker A; Constantinidis J; Conti DM; De Corso E; Desrosiers M; Diamant Z; Gevaert P; Han JK; Heffler E; Hopkins C; Landis BN; Lourenco O; Lund V; Luong AU; Mullol J; Peters A; Philpott C; Reitsma S; Ryan D; Scadding G; Senior B; Tomazic PV; Toskala E; Van Zele T; Viskens AS; Wagenmann M; Fokkens WJ
Allergy; 2024 May; 79(5):1123-1133. PubMed ID: 38108602
[TBL] [Abstract][Full Text] [Related]
2. EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.
Fokkens WJ; De Corso E; Backer V; Bernal-Sprekelsen M; Bjermer L; von Buchwald C; Chaker A; Diamant Z; Gevaert P; Han J; Hopkins C; Hox V; Klimek L; Lund VJ; Lee S; Luong A; Mullol J; Peters A; Pfaar O; Reitsma S; Toppila-Salmi S; Scadding GK; Sedaghat AR; Viskens AS; Wagenmann M; Hellings PW
Rhinology; 2024 Jun; 62(3):287-298. PubMed ID: 38217529
[TBL] [Abstract][Full Text] [Related]
3. [Difficult-to-treat chronic rhinosinusitis-when the standard treatment is not effective and biologics are not available].
Böscke R
HNO; 2024 Apr; 72(4):231-241. PubMed ID: 38472346
[TBL] [Abstract][Full Text] [Related]
4. [Biologic therapy in patients with severe NSAID-exacerbated respiratory disease and previous aspirin desensitization : Results of a multicentric study].
Staufenberg AR; Frankenberger HK; Förster-Ruhrmann U; Spahn FC; Klimek L; Fruth K; Stihl C; Matthias C; Gröger M; Hagemann J
HNO; 2024 Jul; 72(7):473-483. PubMed ID: 38466409
[TBL] [Abstract][Full Text] [Related]
5. Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps.
van der Lans R; Otten JJ; Adriaensen GFJPM; Benoist LBL; Cornet ME; Hoven DR; Rinia AB; Fokkens WJ; Reitsma S
Rhinology; 2024 Jun; 62(3):383-384. PubMed ID: 38478151
[TBL] [Abstract][Full Text] [Related]
6. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L
HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556
[TBL] [Abstract][Full Text] [Related]
7. Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA.
Claeys N; Teeling MT; Legrand P; Poppe M; Verschueren P; De Prins L; Cools L; Cypers L; Fokkens WJ; Hopkins C; Hellings PW
Front Allergy; 2021; 2():761388. PubMed ID: 35386961
[No Abstract] [Full Text] [Related]
8. [Chronic rhinosinusitis with nasal polyposis : A retrospective analysis of therapeutic approaches in 463 patients].
Strauss J; Lochbaum R; Hoffmann TK; Mayer B; Appel H; Hahn J
HNO; 2024 Jul; 72(7):464-472. PubMed ID: 38700581
[TBL] [Abstract][Full Text] [Related]
9. Nasal polyp syndrome: a patient-centred term for CRSwNP by EUFOREA.
Teeling T; Djouder C; Laurens H; Preyra JH; Shire CME; Van Staeyen E; Conti DM; Scadding GK; Hellings PW
Front Allergy; 2024; 5():1372919. PubMed ID: 38596453
[TBL] [Abstract][Full Text] [Related]
10. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management.
Bachert C; Han JK; Wagenmann M; Hosemann W; Lee SE; Backer V; Mullol J; Gevaert P; Klimek L; Prokopakis E; Knill A; Cavaliere C; Hopkins C; Hellings P
J Allergy Clin Immunol; 2021 Jan; 147(1):29-36. PubMed ID: 33227318
[TBL] [Abstract][Full Text] [Related]
11. Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps.
Caminati M; De Corso E; Ottaviano G; Pipolo C; Schiappoli M; Seccia V; Spinelli FR; Savarino EV; Gisondi P; Senna G
Curr Allergy Asthma Rep; 2024 Jan; 24(1):11-23. PubMed ID: 38085499
[TBL] [Abstract][Full Text] [Related]
12. [Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics].
Hoffmann AS; Betz CS; Böscke R; Weber RK
HNO; 2024 Apr; 72(4):225-230. PubMed ID: 38376799
[TBL] [Abstract][Full Text] [Related]
13. High Discontinuation Rates of Peroral ASA Treatment for CRSwNP: A Real-World Multicenter Study of 171 N-ERD Patients.
Laulajainen-Hongisto A; Turpeinen H; Vento SI; Numminen J; Sahlman J; Kauppi P; Virkkula P; Hytönen M; Toppila-Salmi S
J Allergy Clin Immunol Pract; 2020; 8(10):3565-3574. PubMed ID: 32693216
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilia, asthma, NERD and the use of oral corticosteroids predict uncontrolled chronic rhinosinusitis with nasal polyps after surgery.
Penttilä E; Sillanpää S; Vento SI; Myller J; Koskinen A; Hammarén-Malmi S; Laulajainen-Hongisto A; Hytönen M; Lyly A; Lilja M; Kauppi P; Numminen J; Rautiainen M; Sahlman J; Nuutinen M; Toppila-Salmi S; Virkkula P
Asian Pac J Allergy Immunol; 2024 Mar; 42(1):50-60. PubMed ID: 34542306
[TBL] [Abstract][Full Text] [Related]
15. Management of chronic rhinosinusitis with nasal polyps in the Asia-Pacific region and Russia: Recommendations from an expert working group.
Karpischenko S; Jung YG; Kim DW; Spriggs K; Tsang RK; Yeh TH
Asia Pac Allergy; 2024 Jun; 14(2):77-83. PubMed ID: 38827258
[TBL] [Abstract][Full Text] [Related]
16. Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective.
van der Lans RJL; Hopkins C; Senior BA; Lund VJ; Reitsma S
J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1454-1461. PubMed ID: 35231626
[TBL] [Abstract][Full Text] [Related]
17. [Current diagnostics and therapy in chronic rhinosinusitis].
Meier L; Schlegel C
Praxis (Bern 1994); 2024 May; 113(5):119-123. PubMed ID: 38864103
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for chronic rhinosinusitis with nasal polyps.
Wallace DV
Allergy Asthma Proc; 2021 Nov; 42(6):450-460. PubMed ID: 34871152
[No Abstract] [Full Text] [Related]
19. EUFOREA consensus on biologics for CRSwNP with or without asthma.
Fokkens WJ; Lund V; Bachert C; Mullol J; Bjermer L; Bousquet J; Canonica GW; Deneyer L; Desrosiers M; Diamant Z; Han J; Heffler E; Hopkins C; Jankowski R; Joos G; Knill A; Lee J; Lee SE; Mariën G; Pugin B; Senior B; Seys SF; Hellings PW
Allergy; 2019 Dec; 74(12):2312-2319. PubMed ID: 31090937
[TBL] [Abstract][Full Text] [Related]
20. Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement.
De Corso E; Bilò MB; Matucci A; Seccia V; Braido F; Gelardi M; Heffler E; Latorre M; Malvezzi L; Pelaia G; Senna G; Castelnuovo P; Canonica GW
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
